Brugada syndrome and Brugada-type electrocardiogram

Area of Science:

• Cardiology
• Genetics
• Electrophysiology

Background:

• Brugada syndrome is an inherited, arrhythmogenic, nonstructural heart disease.
• It is characterized by ST segment elevation in right precordial leads and male predominance.
• SCN5A gene mutations are found in 20%-30% of patients, but low penetrance leads to variable clinical outcomes.

Purpose of the Study:

• To review the current understanding of Brugada syndrome's cellular mechanisms, prevalence, and prognosis.
• To highlight the challenges in risk stratification for asymptomatic individuals with Brugada-type ECG.
• To emphasize the need for population-based genetic epidemiology studies with long-term follow-up.

Main Methods:

• Review of existing literature on Brugada syndrome.
• Analysis of genetic factors, particularly SCN5A mutations.
• Discussion of clinical manifestations, ECG characteristics, and prognostic indicators.

Main Results:

• Brugada syndrome presents with variable clinical manifestations due to low gene penetrance.
• Asymptomatic individuals with Brugada-type ECG pose a challenge for sudden cardiac death risk stratification.
• Conflicting data exist regarding the syndrome's prevalence and prognosis.

Conclusions:

• Further population-based genetic epidemiology studies are needed to clarify the clinical outcomes of Brugada syndrome.
• Longer follow-up periods are essential for accurate prognosis, especially in asymptomatic patients.
• Understanding the genetic basis and clinical variability is crucial for managing Brugada syndrome.